Kevin Bigart, MD
Adult Reconstructive Orthopaedic Surgery · New Lenox, ILNPI 1578901799
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (45.5%), education and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Zimmer Biomet at 55.2% of the total. Reporting peaked in 2019 at $9,809 and has fallen 70.6% since, to $2,880 in 2025.
Across 71 payments — averaging $233.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$9K
- Smith+Nephew$5K
- Encore Medical, LP$2K
- Stryker$461
- Fidia Pharma USA Inc.$112
- Medtronic$100
- plus $536 from 10 others
What the payments were for
- Speaking & faculty fees$1,5009%
- Travel & lodging$7,53045%
- Food & beverage$3,72623%
- Education$3,80123%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 26 | $9,145 |
| Smith+Nephew | 6 | $4,653 |
| Encore Medical, LP | 3 | $1,550 |
| Stryker | 9 | $461 |
| Fidia Pharma USA Inc. | 6 | $112 |
| Medtronic | 1 | $100 |
| Orthofix Medical, Inc. | 5 | $97 |
| Exactech, Inc. | 1 | $95 |
| Johnson & Johnson(2 entities) | 4 | $89 |
| Biocomposites Inc | 2 | $82 |
| UOC USA Inc | 3 | $47 |
| Sanofi-aventis U.S. LLC | 1 | $32 |
| Solventum Corporation | 1 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| Convatec Inc. | 1 | $21 |
| Conmed Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Avenir$2,942
- Persona$2,292
- DJO Surgical TaperFill Hip System$1,500
- DJO Surgical Empowr Knee System$1,500
- Journey II XR$734
- Navio Surgical System$734
- REDAPT Revision Hip System$368
- JII Unicondylar Knee System$367
- MAKO$150
- Knees Product Portfolio$150
- T2$113
- AQUAMANTYS$100
How this compares
$16,557 in reported general payments places this provider in the 55th percentile of 67 adult reconstructive orthopaedic surgery providers in Illinois.
See all adult reconstructive orthopaedic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 102 | $914 |
| Meloxicam | 42 | $197 |
| Amoxicillin | 88 | $92 |
| Methylprednisolone | 16 | $90 |
| Clindamycin Hcl | 22 | $31 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in New Lenox
- Wayne PaproskyWinfield$10.9M
- Scott SporerWinfield$5.3M
- Denis NamChicago$3.2M
- Craig della ValleChicago$2.4M
- Hany BedairChicago$1.1M
- Linda SuleimanChicago$898K
- Tad GerlingerChicago$642K
- Henry FinnChicago$523K
- Vasili KarasChicago$264K
- Brett LevineChicago$250K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.